Anastasia Skripkina

Anastasia Skripkina

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2024 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
PDF file
ENElena Nikulina
Elena Nikulina
NRNatalya Risinskaya
Natalya Risinskaya
ODO. E. Dubova
O. E. Dubova
OSO. V. Sumtsova
O. V. Sumtsova
YMYa. G. Moysyuk
Ya. G. Moysyuk
ЯМЯ. Г. Мойсюк
Я. Г. Мойсюк
Introduction. The analysis of free circulating DNA (cfDNA) holds promise for molecular diagnostics, but its fragmentation and low concentration can complicate PCR analysis.Objective. To investigate the effect of target length on the amplification efficiency of Y-chromosome markers from cfDNA.Material and methods. Fifty cfDNA samples were obtained from 39 patients: patients after liver transplantation (n=19), patients with acute leukemia after allogeneic hematopoietic stem cell transplantation (n=10), and pregnant women (n=10). In addition, we prepared 16 chimeric samples by sequential dilution of male cfDNA into female cfDNA from healthy donors. We determined the proportion of male cfDNA using the Y-chromosome marker S02, which is 211 bp in length as suggested by M. Alizadeh et al. We also modified Alizadeh's primer design to obtain a DNA target with a length of 138 bp. The proportion of male cfDNA was also determined by fragment analysis using the amelogenin Y marker (84 bp) from the COrDIS Plus kit (Gordiz LLC, Russia).Results. In the three groups of patients, amplification of male cfDNA was more efficient when shorter DNA targets were used (p<0.05). In artificially created ‘chimeras’ with a known ratio of male to female cfDNA, analysis of a marker of 84 bp in length gave values closest to the real ones.Conclusions. In the quantitative models tested so far, shorter PCR targets are preferred for the analysis of cfDNA.

Verified
Journal Article
Open access
PDF file
ASAnastasia Skripkina
Anastasia Skripkina
IFIrina Fevraleva
Irina Fevraleva
EKElena Kuzmina
Elena Kuzmina
BBBella Biderman
Bella Biderman
ESElena Stepanova
Elena Stepanova
ASAndrey Sudarikov
Andrey Sudarikov
Missense mutations in the BCR::ABL1 kinase domain are found in approximately 12–80% of patients with chronic myeloid leukemia (CML). Clinically significant mutations include T315I, M244V, Y253H/F, E255K/V, V299L, and F359V. The aim of this study was to create a diagnostic system for rapid and inexpensive detection of the above mutations. We used genomic DNA and RNA from peripheral blood and bone marrow cells of 57 patients with a Ph-positive CML diagnosis established in the chronic phase. We have developed a method to detect mutations in the BCR::ABL1 gene based on allele-specific real-time polymerase chain reaction (AS-PCR). In parallel, we analyzed the RNA sequence of the protein kinase domain of the same samples by next-generation sequencing (NGS) covering the points of putative mutations. In this work, we compared the results obtained by both methods for mutation detection and variant allele frequency (VAF) estimation of mutated vs. normal alleles. The sensitivity and specificity of our diagnostic system were also evaluated. It was found that AS-PCR gives reliable results at VAF up to 0.01%. AS-PCR has high sensitivity and may serve as an alternative for the more time-consuming NGS in some cases, as well as for monitoring CML treatment and for analyzing archival material.